Furthermore, SPP1 shows a strong association with oral leukoplakia driven by HNSCC, highlighting its potential as a diagnostic and prognostic biomarker, as well as a promising therapeutic target for HNSCC [42]. Here, SPP1 is linked to head and neck squamous cell carcinoma.